Goedgekeurd onderzoek

Hieronder vindt u een lijst met GIANTT-onderzoek dat is goedgekeurd door de Stuurgroep en momenteel loopt:

Overview of approved GIANTT studies

201633HbA1c trajectories after initiation of insulin in patients with diabetesGrigory SidorenkovPublished
201735Prescription trends of novel glucose regulating medication in type 2 diabetes in the Northern part of the NetherlandsKlaas Hoogenberg Searching for funding
201736Type 2 diabetes treatment in the elderly: trends in the era of implementing age-dependent targetsKlaas HoogenbergPublished
201737Population based screening compared to opportunistic screening for type 2 diabetes: comparable medication needs?Rimke VosPublished
201738The role of differences in drug prescribing (e.g. drug selection, dosing, comedication) in relation to sex differences in adverse drug reactions in people with type 2 diabetes Sieta de VriesPublished
201839Decreasing hypoglycaemia risk in type 2 diabetes: Identifying patients at high riskStijn CrutzenPublished
202040adverse events in relation to systolic blood pressure levels and antihypertensive treatment according to sex, age and frailtyMartina AmbrozPublished
202041Differences during the life course in the lipid spectrum between men and women with type 2 diabetes and the effect on it of statinsSieta de VriesPublished
202042Sex differences in treatment decisions and effects in type 2 diabetes patientsMonik OktoraPublication submitted
202043The Impact of Sex on Quality of Medication Treatment in Patients with Type 2 DiabetesMarit GeelinkPublished
202144Identifying risk factors for breast cancer susceptibility in women with pre-existing type 2 diabetes mellitus based on a Dutch populationGrigory SidorenkovPublished
202145Relationship between triglyceride/HDL-cholesterol ratio, glucose-lowering medication and cardiovascular disease in people with type 2 diabetesFieke TeerstraStudy in progress
202346The potential value of the intensive treat-to-target statin therapy in the Netherlands Anjali HoodStudy in progress
202347Cost-effectiveness evaluation of additional treatment with SGLT2 inhibitors on diabetic nephropathy outcomesNgoc Thuy Tram NguyenStudy in progress